Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy

被引：0

作者：

Moreno, S. Flores ^{[1
]}

Paloma, J. Bautista ^{[2
]}

机构：

[1] Andalusian Agcy Hlth Technol Assessment, Seville 41006, Spain

[2] Virgen Rocio Hosp, Seville, Spain

来源：

BRITISH JOURNAL OF OPHTHALMOLOGY | 2008年 / 92卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：866 / 867

页数：8

共 50 条

[1] Intravitreal anti-VEGF therapy in neovascular age-related macular degeneration: Bevacizumab versus Ranibizumab
Zehetner, C.
Kralinger, M. T.
Kieselbach, G. F.
SPEKTRUM DER AUGENHEILKUNDE, 2008, 22 (06) : 370 - 375
[2] Anti-VEGF agents for age-related macular degeneration
Ozkiris, Abdullah
EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (01) : 103 - 118
[3] Ranibizumab for age-related macular degeneration: a meta-analysis of dose effects and comparison with no anti-VEGF treatment and bevacizumab
Jiang, S.
Park, C.
Barner, J. C.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (03) : 234 - 239
[4] The results of switching between 2 anti-VEGF drugs, bevacizumab and ranibizumab, in the treatment of neovascular age-related macular degeneration
Aslankurt, Murat
Aslan, Lokman
Aksoy, Adnan
Erden, Burak
Cekic, Osman
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (04) : 553 - 557
[5] Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: Therapeutic Strategies
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 541 - 547
[6] Anti-VEGF therapies for the treatment of age-related macular degeneration
Gower, Emily W.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2012, 1 (06) : 485 - 488
[7] Neovascular age-related macular degeneration and anti-VEGF nonresponders
Sheybani, Arsham
Almony, Arghavan
Blinder, Kevin J.
Shah, Gaurav K.
EXPERT REVIEW OF OPHTHALMOLOGY, 2010, 5 (01) : 35 - 41
[8] Bevacizumab (Avastin) conjugated microbubbles for anti-VEGF treatment of neovascular age-related macular degeneration
Zhang, Leilei
Xu, Jeff
Huang, Jiwei
Roberts, Cynthia
Xu, Ronald
OPHTHALMIC TECHNOLOGIES XX, 2010, 7550
[9] Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye
Isildak, Hacer
Schwartz, Stephen G.
Flynn, Harry W., Jr.
CASE REPORTS IN OPHTHALMOLOGICAL MEDICINE, 2018, 2018
[10] Intravitreal anti-VEGF therapy in neovascular age-related macular degeneration: Bevacizumab versus RanibizumabIntravitreale anti-VEGF Therapie bei neovaskulärer altersabhängiger Makuladegeneration: Bevacizumab versus Ranibizumab
C. Zehetner
M. T. Kralinger
G. F. Kieselbach
Spektrum der Augenheilkunde, 2008, 22 (6) : 370 - 375

← 1 2 3 4 5 →